SS 17 - Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

Presentations

• 10:45am - 12:00pm PT

  Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

  Speaker: Mohammad Khan, MD, PhD - Emory University, Atlanta
• 10:45am - 12:00pm PT

  Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

  Speaker: Penny Fang, MD, MBA - MD Anderson Cancer Center, Houston
• 10:45am - 10:55am PT

  Improved Progression-Free and Overall Survival with Radiotherapy Consolidation Post-Autologous Stem Cell Transplant in Patients with Relapsed/Refractory Aggressive Lymphoma with Pre-Transplant Partial

  Speaker: Chathuri Abeyakoon, MBBS - Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto
• 10:55am - 11:05am PT

  TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma

  Speaker: Alok Deshane, MD - MSKCC, New York
• 11:05am - 11:15am PT

  Treatment Kinetics and Local Response during and after Bridging Radiotherapy prior to CAR-T Cell Therapy for Lymphomas

  Speaker: Dasha Klebaner, MD, BS, MPH - Stanford University Cancer Center, La Jolla
• 11:15am - 11:25am PT

  CNS Bridging Radiotherapy prior to CAR T-Cell Therapy for B-Cell Lymphomas

  Speaker: Pule Wang, MD, BS - City of Hope Cancer Center, Duarte
• 11:25am - 11:35am PT

  Mechanisms of Acquired Radioresistance in Diffuse Large B-Cell Lymphoma

  Speaker: Fabian Troschel, MD, cand. med. - WWU Muenster, Muenster
• 11:35am - 11:45am PT

  Discussant

  Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham